Medical Company Secures European Patent For Human Klotho Gene

ANEW MEDICAL, INC. (NASDAQ: WENA), a biopharmaceutical company, has announced a noteworthy development in its pursuit of innovative treatments for neurological and age-related disorders. The European Patent Office has granted and issued patent EP3377091B1, which covers the use of ANEW's secreted Klotho gene sequence and gene delivery systems. This technology is designed for the treatment of cognitive decline, memory impairment, dementia, and other neurodegenerative diseases. $Anew Medical(WENA.US)$